Sanofi-Aventis Korea Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sanofi-Aventis Korea Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10661
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanofi-Aventis Korea Co Ltd (Sanofi-Aventis), a subsidiary of Sanofi is a developer, manufacturer and distributor of generic drugs and medical equipment. The company’s products include note vials lantus, lantus state solo star, she feeds the main vial la, feed her a solo star la shares, elrok satin shares, taxotere shares, taxotere 1 – vial week, pass teotek shares, megeve tana shares, timothy globulin injection, flu dara shares, dara flu tablets, imitation villejuif, and evolution trapani province, among others. It offers drugs for the treatment of diabetes, anticancer, thrombosis, cardiovascular disease, medical area, central nervous system diseases and other treatments. Sanofi-Aventis is headquartered in Seoul, South Korea.

Sanofi-Aventis Korea Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
PharmAbcine Enters Into Research Agreement With Sanofi For Antibody Drug Discovery 10
Hanmi Pharma Enters Into Co-Marketing Agreement With Sanofi-Aventis For Ibestin 11
LG Life Sciences Enters Into Co-Promotion Agreement With Sanofi-Aventis Korea For Zemiglo 12
Sanofi-Aventis Korea Co Ltd – Key Competitors 13
Sanofi-Aventis Korea Co Ltd – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanofi-Aventis Korea Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PharmAbcine Enters Into Research Agreement With Sanofi For Antibody Drug Discovery 10
Hanmi Pharma Enters Into Co-Marketing Agreement With Sanofi-Aventis For Ibestin 11
LG Life Sciences Enters Into Co-Promotion Agreement With Sanofi-Aventis Korea For Zemiglo 12
Sanofi-Aventis Korea Co Ltd, Key Competitors 13

List of Figures
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanofi-Aventis Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sanofi-Aventis Korea Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Quaterra Resources Inc (QTA):企業の財務・戦略的SWOT分析
    Summary Quaterra Resources Inc (Quaterra Resources) is a copper exploration company that acquires and operates copper projects. The company's activities include acquisition, exploration and development of gold, silver, and copper deposits in Canada. Its projects comprise Quaterra’s Yerington Copper …
  • Polski Koncern Naftowy Orlen SA (PKN):企業の財務・戦略的SWOT分析
    Polski Koncern Naftowy Orlen SA (PKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Mymetics Corp (MYMX)-製薬・医療分野:企業M&A・提携分析
    Summary Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company's product pipeline includes vaccine candidates that target HIV-1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus (HSV) and respi …
  • Industrial Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Kansas Electric Power Cooperative, Inc.:発電所・企業SWOT分析
    Kansas Electric Power Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Godrej Agrovet Limited (GODREJAGRO):企業の財務・戦略的SWOT分析
    Godrej Agrovet Limited (GODREJAGRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tanfield Group PLC (TAN):企業の財務・戦略的SWOT分析
    Summary Tanfield Group plc (Tanfield Group) is an investment company that offers electrical investments. The company designs and produces electric commercial vehicles for short haul urban fleets. It also produces zero-emission vehicles that deliver better performance to traditional diesel trucks. Ta …
  • Greif, Inc. (GEF):企業の財務・戦略的SWOT分析
    Greif, Inc. (GEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Noble Group Ltd:企業のM&A・事業提携・投資動向
    Noble Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Noble Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Micropole SA (MUN):企業の財務・戦略的SWOT分析
    Micropole SA (MUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Public Gas Corporation SA:企業の戦略的SWOT分析
    Public Gas Corporation SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Abu Dhabi National Hotels Company:企業の戦略・SWOT・財務分析
    Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Assystem SA (ASY):企業の財務・戦略的SWOT分析
    Assystem SA (ASY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Evonik Industries AG (EVK):製薬・医療:M&Aディール及び事業提携情報
    Summary Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemicals company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets, including adhesives and sealants, automotive, agricul …
  • Animal Health International Inc:企業の戦略的SWOT分析
    Animal Health International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Naked Wines plc (WINE):企業の財務・戦略的SWOT分析
    Naked Wines plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • VT Holdings Co Ltd (7593):企業の財務・戦略的SWOT分析
    VT Holdings Co Ltd (7593) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • National Grid USA Service Company Inc:企業の戦略的SWOT分析
    National Grid USA Service Company Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Business Development Bank of Canada:企業のM&A・事業提携・投資動向
    Business Development Bank of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Business Development Bank of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Torii Pharmaceutical Co Ltd (4551):製薬・医療:M&Aディール及び事業提携情報
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆